ConductScience.org, home

Paper33859757

Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension.

Luo LJ and 2 others. Theranostics, 2021. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension. Papers, record 33859757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859757

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension.
PubMed
Journal
Theranostics
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
6.7
iCite
Revised in PubMed
2022-02-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Luo LJLi-Jyuan
2Nguyen DDDuc Dung
3Lai JYJui-Yang

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmidesMajor topic
NanoparticlesMajor topic
NitroimidazolesMajor topic
Ocular HypertensionMajor topic
PyridinesMajor topic
Animals
Cell Line
Delayed-Action Preparations
Disease Models, Animal
Drug Carriers
Drug Delivery Systems
Drug Liberation
Eye
Glaucoma
Humans
Ophthalmic Solutions
Photoreceptor Cells
Rabbits

Source PubMed

Download CSV of topics

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117516712Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma.BioDrugs2007https://conductscience.org/library/papers/17516712PubMed
223142993Anterior chamber paracentesis and pH values in patients with acute primary angle closure.Graefes Arch Clin Exp Ophthalmol2013https://conductscience.org/library/papers/23142993PubMed
324872673An emerging treatment option for glaucoma: Rho kinase inhibitors.Clin Ophthalmol2014https://conductscience.org/library/papers/24872673PubMed
417222903Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons.Biomaterials2007https://conductscience.org/library/papers/17222903PubMed
527544758Glaucoma: the retina and beyond.Acta Neuropathol2016https://conductscience.org/library/papers/27544758PubMed
620467456Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome.Mediators Inflamm2010https://conductscience.org/library/papers/20467456PubMed
721396448Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways.Neurobiol Dis2011https://conductscience.org/library/papers/21396448PubMed
810416754Neuroprotection in relation to retinal ischemia and relevance to glaucoma.Surv Ophthalmol1999https://conductscience.org/library/papers/10416754PubMed
911018042Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase.J Biol Chem2001https://conductscience.org/library/papers/11018042PubMed
1010640587Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.J Control Release2000https://conductscience.org/library/papers/10640587PubMed
1115919228Changes in aqueous humor dynamics with age and glaucoma.Prog Retin Eye Res2005https://conductscience.org/library/papers/15919228PubMed
1218758924Recent perspectives in ocular drug delivery.Pharm Res2009https://conductscience.org/library/papers/18758924PubMed
1322562850Advances in glaucoma treatment and management: outflow drugs.Invest Ophthalmol Vis Sci2012https://conductscience.org/library/papers/22562850PubMed
1421442374Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.Pharm Res2011https://conductscience.org/library/papers/21442374PubMed
1524294000Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation.Int J Nanomedicine2013https://conductscience.org/library/papers/24294000PubMed
1628738764Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases.Curr Neuropharmacol2018https://conductscience.org/library/papers/28738764PubMed
1727575454Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks.Expert Opin Drug Deliv2017https://conductscience.org/library/papers/27575454PubMed
1822815626A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma.Mol Vis2012https://conductscience.org/library/papers/22815626PubMed
1917207782Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy.Cardiovasc Res2007https://conductscience.org/library/papers/17207782PubMed
2026881021The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults.Oxid Med Cell Longev2016https://conductscience.org/library/papers/26881021PubMed

See all 62 referencesDownload CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
42898393Application of nanozyme-based drug delivery systems in the treatment of ROS-related ophthalmic diseases.Int J Pharm X2026https://conductscience.org/library/papers/42898393PubMed
42835137Mannan-oligosaccharides-based self-assembly nanoparticles enable gut-specific quercetin release, providing multi-pathway protection against AD via gut-brain axis.J Pharm Anal2026https://conductscience.org/library/papers/42835137PubMed
42518473Light-Triggered and Sustained Delivery of Dexamethasone Using Chitosan-Coated PLGA Nanoparticles for Posterior Eye Disease Treatment.ACS Omega2026https://conductscience.org/library/papers/42518473PubMed
42388372Shattering the "golden armor": A natural supramolecular nanoplatform for optical virulence modulation and MRSA keratitis therapy.Mater Today Bio2026https://conductscience.org/library/papers/42388372PubMed
42063460ROS-responsive drug delivery systems for chronic wound healing: advances, challenges, and translational perspectives.Mil Med Res2026https://conductscience.org/library/papers/42063460PubMed
41840931Development of a Cerium-Doped Titanate/Polyphenol Nanostructured Coating for Titanium Implants: Enhancing Antibacterial Properties through Ciprofloxacin Release.ACS Appl Mater Interfaces2026https://conductscience.org/library/papers/41840931PubMed
41725008Chitosan-rapamycin carbon dots rejuvenate autologous Sca-1⁺ stem cells paracrine function for neuroprotection in normal tension glaucoma.Stem Cell Res Ther2026https://conductscience.org/library/papers/41725008PubMed
41692731Mucoadhesive and corneal permeable nano eye drops for improved anti-glaucoma therapy.J Nanobiotechnology2026https://conductscience.org/library/papers/41692731PubMed
41578928Dual-functional nanoparticle formulations for simultaneous intraocular pressure reduction and neuroprotection in glaucoma: a review.Nanomedicine (Lond)2026https://conductscience.org/library/papers/41578928PubMed
41563533Adverse effects of antiglaucoma medications: pathophysiology and novel drug delivery strategies for mitigation.Int Ophthalmol2026https://conductscience.org/library/papers/41563533PubMed
41535853Single-atom Pt doped nanoceria for enhanced cell phagocytosis and nanozyme activities in keratitis immune regulation.J Nanobiotechnology2026https://conductscience.org/library/papers/41535853PubMed
41470223Cell Motility Dynamics in Glaucoma: Mechanisms, Pathogenic Roles, and Therapeutic Targeting.Medicina (Kaunas)2025https://conductscience.org/library/papers/41470223PubMed
41234295Next-generation smart ophthalmic biomaterials: From passive response to active interaction and closed-loop control.Bioact Mater2026https://conductscience.org/library/papers/41234295PubMed
40868931A Comprehensive Review of the Role of Rho-Kinase Inhibitors in Corneal Diseases.Life (Basel)2025https://conductscience.org/library/papers/40868931PubMed
40856634Evaluating the potential of travoprost-thymoquinone co-loaded liposomes: a glaucomatous rabbit model study.Ther Deliv2025https://conductscience.org/library/papers/40856634PubMed
40001147Frontier applications of retinal nanomedicine: progress, challenges and perspectives.J Nanobiotechnology2025https://conductscience.org/library/papers/40001147PubMed
39897787Drug delivery strategies to improve the treatment of corneal disorders.Heliyon2025https://conductscience.org/library/papers/39897787PubMed
39818739Advancements and Prospects in Nanorobotic Applications for Ophthalmic Therapy.ACS Biomater Sci Eng2025https://conductscience.org/library/papers/39818739PubMed
39768626Meta-Analysis of MINIject vs. Two iStents as Standalone Treatment for Glaucoma with 24 Months of Follow-Up.J Clin Med2024https://conductscience.org/library/papers/39768626PubMed
39596335Müller Glia Co-Regulate Barrier Permeability with Endothelial Cells in an Vitro Model of Hyperglycemia.Int J Mol Sci2024https://conductscience.org/library/papers/39596335PubMed

See all 41 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATP1A1476PubTator's text mininghttps://conductscience.org/library/genes/476NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33859757

GET https://conductscience.org/api/papers/v1/33859757/references?page=2